While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth.

GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of optimism about sales of its new drugs ...

GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...

Elon Musk's rapid takeover of two U.S. government agencies has enabled the South African-born billionaire to exert ...

It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.

The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such ...

GSK has announced that the European Medicines Agency (EMA) has accepted its regulatory application for a prefilled syringe presentation of Shingrix ...

GSK and the University of Oxford have launched the GSK-Oxford Cancer Immuno-Prevention Programme, a new research initiative focused on cancer preve ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Join the Cupid Crew to send heartfelt cards to older adults at ...

This neatly summarizes the location tracking industry which has been created by the always on, always aware devices we now carry with us everywhere we go. NSA warns that “mobile devices store ...

As with other Mr. Beast-related projects, Beast Games was a massive undertaking, with an incredibly high production budget and amazing filming locations. The content creator went to great lengths ...